Market access and
evidence generation strategy
Health
At LCP, we understand that developing a comprehensive real-world evidence (RWE) strategy is not just a necessity, but a game-changer for life science companies.
Leveraging our deep expertise, we help our clients develop holistic strategies that plan for all RWE needs across all stages of the medicine lifecycle. A RWE strategy can also be incorporated into strategies developed for reimbursement.
RWE use across the product lifecycle
How life sciences can address the greatest health challenges and reduce inequalities
Health Analytics report
Explore our report which sets out how the life sciences sector has a unique opportunity to actively reduce health inequalities.
Read nowHow we can help
From early-stage development to post-marketing surveillance, our team works hand in hand with our clients, ensuring plans are made to address needs key stakeholder groups robustly and in time. Whether it's regulatory, market access, HEOR, medical affairs, or safety, we provide tailored advice that align with clients’ specific objectives and requirements, making sure they get the most value from RWE for molecule.
In a rapidly evolving healthcare landscape, access to diverse and robust data sources is critical. Our team stays abreast of emerging data sources and can advise on which sources would be suitable for our clients’ needs.
Looking ahead, we see the enormous potential that emerging technologies like artificial intelligence (AI) have to offer for the field. We're keeping pace with these technological developments and can advise accordingly as to when to incorporate into an RWE strategy.
At LCP, we're more than just a service provider – we're a strategic partner in developing and implementing effective RWE strategies that drive success. Let us help you unlock the full potential of your molecules and pave the way for a future where every healthcare decision is well-informed, effective, and equitable. Contact us today to learn more about how we can support your RWE journey.
Resources
Is AI shaping the future of the NHS?
LCP Partners Laura Amin and Ben Bray delve into the various ways in which artificial intelligence (AI) can revolutionise the NHS.
Why our health system must shift from sickness to prevention to make it sustainable for our future society
In this article, our experts discuss the benefits of shifting the NHS's focus from primarily treating sickness to prioritising prevention.
Our Market access and evidence generation strategy experts
Related publications
Explore our solutions
Multimorbidity, living with two or more conditions is one of the biggest challenges facing patients and health systems today. We leverage real world datasets and innovative approaches to generate evidence that identifies patient groups with the greatest unmet needs in a more holistic manner that reflects the drivers of ill health.
We apply scientific rigour to evaluate the economic and clinical value of healthcare interventions using both traditional and innovative perspectives and methods.
Supporting our clients to achieve equitable health outcomes is a golden thread throughout our work. We combine our expertise to translate evidence into change and apply population health analytics to help reduce inequalities in health and health outcomes.
We integrate a wealth of health and health-related datasets and develop bespoke interactive visualisations to make it accessible and rapid for clients to glean insights across a range of areas.